This section focuses on recent global studies and discoveries in the various fields of healthcare.
Neurodegenerative diseases encompass a group of debilitating conditions resulting from progressive nerve cell death Of these Alzheimers disease AD occurs most frequently but is currently incurable and has limited treatment success
Leftsided breast cancer patients receiving adjuvant radiotherapy are at risk for coronary artery disease andor radiation mediated effects on the microvasculature
There is little prospective data to guide effective dosing for antibiotic prophylaxis during surgery requiring cardiopulmonary bypass CPB We aim to describe the effects of CPB on the population pharmacokinetics
Despite development of effective SARSCoV vaccines a subgroup of vaccine nonresponders depends on therapeutic antibodies or smallmolecule drugs in cases of severe disease
Cardiac device infection CDI can occur in up to of patients after device placement with mortality rates exceeding Although device removal is standard management
Rab GTPases play key roles in controlling intracellular vesicular transport GTPbound Rab proteins support vesicle trafficking Here we report that unlike cellular protein cargos retromermediated delivery of human papillomaviruses
Predicting the duration of ventilation in the ICU helps in assessing the risk of ventilatorinduced lung injury ensuring sufficient oxygenation and optimizing resource allocation
This study determined whether initiation of pharmacologic treatment was delayed for newly diagnosed osteoporosis patients during the COVID pandemic
Dual antiplatelet therapy DAPT following percutaneous coronary intervention PCI reduces major adverse cardiovascular events MACE and stent thrombosis However DAPT duration is a concern in high bleeding risk HBR patients
To evaluate the central venoustoarterial carbon dioxide difference combined with arterialtovenous oxygen content difference PvaCOCavO ratio as a predictor of mortality in patients with COVIDrelated severe acute respiratory distress syndrome ARDS
